Title: The Next Frontier in Precision Oncology
Co-hosts: HCA, Madano and Women in Pharma
Speakers:
1. Dr Berna Özdemir - Senior Medical Oncology Consultant, University Hospital Bern; Founding Member, ESMO Gender Medicine Taskforce
2. Linda Geddes - Health Writer, The Guardian
3. Merel Hennink - Secretary of the Board, Cancer Patients Europe (CPE) and Board Member, Lung Cancer Europe (LuCE)
4. Max Taylor McEwan - Research Director at Madano
Description:
For the past two decades, the pursuit of precision has transformed cancer care — delivering treatments that are smarter, more targeted, and increasingly personal.
Real progress has been made — yet outcomes still vary widely. Understanding why patients respond so differently is key to reaching the next frontier.
This hybrid session explored the next frontier in precision oncology: understanding the human factors that shape how cancer develops, progresses, and responds to treatment. It looked at the biological, behavioural, and social variables still underrepresented in cancer research and care, and how clinical, communications, and policy approaches can work together to close these gaps and drive lasting change.
A thought-provoking and practical session for anyone working in healthcare communications, policy, or oncology.